Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 88,261,253.31
    Countries
    Sector(s)
    Argentina : € 88,261,253.31
    Health : € 88,261,253.31
    Signature date(s)
    17/12/2021 : € 88,261,253.31

    Summary sheet

    Release date
    28 June 2021
    Status
    Reference
    Signed | 17/12/2021
    20210373
    Project name
    Promoter - financial intermediary
    ARGENTINA VACCINE PURCHASE
    REPUBLICA ARGENTINA
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    USD 100 million (EUR 85 million)
    USD 1600 million (EUR 1353 million)
    Location
    Sector(s)
    • Health - Human health and social work activities
    Description
    Objectives

    EIB loan to finance the purchase of COVID-19 vaccines.

    The proposed operation consists of an investment loan of up to USD 100 million to the Republic of Argentina, to part to finance the strengthening of the country's resilience and pandemic preparedness initiatives as included in the Argentinian national response plan to the current COVID-19 pandemic. In particular, the project will support the purchase of vaccines and the deployment of vaccination campaigns in alignment with a satisfactory country National Vaccine Deployment Plan (NVDP).

    Additionality and Impact

    In alleviating the strain of the COVID-19 pandemic in LMICs, the project supports Bank's objectives to enhance sustainable social and human development through improved health, education and nutrition services. The project addresses the provision of health services for COVID-19 considered as a Global Public Good. Immunisation is one of the most effective investments in global health and has a crucial role in achieving 14 of the 17 United Nations Sustainable Development Goals (SDGs). As one of the most far-reaching health interventions, it closely reflects the ethos of the SDGs: "leaving no one behind". In particular, the project will contribute to the pursuit of SDG 3 Longer and Healthier lives: Immunisation is one of the most cost-effective ways to ensure long and healthy lives. Every year, vaccines save 2-3 million lives, and millions more are protected from disease and disability. Immunisation has an important role in empowering girls and women through better health through the achievement of equal access to vaccines for boys and girls. Women play a disproportionate role in responding to the COVID-19 virus, including as frontline healthcare workers and carers at home and furthermore often work in the informal economy, which has been heavily impacted by the COVID-19 pandemic. Hence, the project, which enables equitable and fair distribution of SARS-CoV-2 vaccines, is expected to significantly contribute to the achievement of SDG 5 ("Empowered Women And Girls") through the reversal of the negative economic effects that the COVID-19 pandemic has had on women and girls. The partnership between the Bank, the Inter-American Development Bank, World Bank and other IFIs in the fight against COVID-19 in LMICs pursues SDG 17 - Strengthen the means of implementation and revitalize the global partnership for sustainable development.

    The project addresses the provision of health services for COVID-19 considered as a Global Public Good and the EIB loan addresses a material market gap in the open and fair access to COVID-19 vaccines.

    Environmental aspects
    Procurement

    The Bank will require the Promoter to ensure that the implementation of the project will be done in accordance with the Bank's Environmental and Social Principles and Standards.

    The Bank will require the Promoter to ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.

    Under ELM Guarantee
    Comments

    This operation is covered by the ELM Guarantee.

    The project will be financed under the 2014-2020 External Lending Mandate or, to the extent possible, its successor Mandate.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - ARGENTINA VACCINE PURCHASE
    Publication Date
    25 Sep 2021
    Document language
    Main Topic
    Lending
    Document Number
    144974590
    Document Focus
    Environmental Information
    Project Number
    20210373
    Sector(s)
    Countries
    Publicly available
    Download now
    Other links

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications